Windtree Therapeutics (WINT) Expected to Announce Quarterly Earnings on Wednesday

Windtree Therapeutics (NASDAQ:WINT) is expected to issue its Q4 2025 results after the market closes on Wednesday, April 8th. Analysts expect Windtree Therapeutics to post earnings of $18.00 per share and revenue of $3.80 million for the quarter. Individuals can find conference call details on the company’s upcoming Q4 2025 earning report page for the latest details on the call scheduled for Wednesday, April 15, 2026 at 12:30 PM ET.

Windtree Therapeutics Trading Up 16.1%

Windtree Therapeutics stock opened at $0.01 on Wednesday. Windtree Therapeutics has a 52 week low of $0.01 and a 52 week high of $1.86. The stock has a market cap of $485,870.40, a P/E ratio of 0.00 and a beta of 0.69. The stock has a 50 day moving average of $0.01 and a 200-day moving average of $0.05.

Windtree Therapeutics Company Profile

Windtree Therapeutics, Inc is a clinical-stage biotechnology company developing innovative therapies for acute cardiovascular and pulmonary conditions. The company leverages its proprietary KL4 surfactant technology to address diseases marked by surfactant deficiency or dysfunction, with a primary focus on acute respiratory distress syndrome (ARDS) in adults and respiratory distress syndrome (RDS) in premature infants.

The company’s lead platform comprises synthetic peptide‐based surfactants designed to restore lung function by reducing surface tension in the alveoli.